Viagra is one of 49 small molecule programs targeting Endothelial Function. It is currently in Phase 1.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
91 competitors in ART
Belamaf
Venclexta
Rituxan
Attruby
Brukinsa
Treanda
Toradol
Cysteine Hydrochloride
Noradrenaline
Vyvgart
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details